Wnt6 is expressed in granulomatous lesions of Mycobacterium tuberculosis-infected mice and is involved in macrophage differentiation and proliferation

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 5182-5195

  Schaale, Kolja ^a,e   Brandenburg, Julius ^a   Kispert, Andreas ^b   Leitges, Michael ^c   Ehlers, Stefan ^a,d   Reiling, Norbert ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; BETA CATENIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; PERTUSSIS TOXIN; THYMIDINE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; WNT6 PROTEIN; ARG1 PROTEIN, MOUSE; ARGINASE; CULTURE MEDIUM; MESSENGER RNA; MKI67 PROTEIN, MOUSE; MYC PROTEIN, MOUSE; MYD88 PROTEIN, MOUSE; ONCOPROTEIN; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2; WNT PROTEIN; WNT6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GRANULOMATOUS INFLAMMATION; IN VITRO STUDY; MACROPHAGE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CULTURE MEDIUM; GENETICS; GRANULOMA; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; LUNG TUBERCULOSIS; METABOLISM; MICROBIOLOGY; PATHOLOGY;

ANIMALS; ARGINASE; BETA CATENIN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRANULOMA; KI-67 ANTIGEN; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PERTUSSIS TOXIN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84887503327     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201819     Document Type: Article

References (63)

1. Russell, D. G., P.-J. Cardona, M.-J. Kim, S. Allain, and F. Altare. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10:943-948.
2. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
3. Jenner, R. G., and R. A. Young. 2005. Insights into host responses against pathogens from transcriptional profiling. Nat. Rev. Microbiol. 3:281-294.
4. Schaale, K., J. Neumann, D. Schneider, S. Ehlers, and N. Reiling. 2011. Wnt signaling in macrophages: augmenting and inhibiting mycobacteria-induced inflammatory responses. Eur. J. Cell Biol. 90:553-559.
5. Sen, M., and G. Ghosh. 2008. Transcriptional outcome of Wnt-Frizzled signal transduction in inflammation: evolving concepts. J. Immunol. 181:4441-4445.
6. Angers, S., and R. T. Moon. 2009. Proximal events in Wnt signal transduction. Nat. Rev. Mol. Cell Biol. 10:468-477.
7. Van Amerongen, R., and R. Nusse. 2009. Towards an integrated view of Wnt signaling in development. Development 136:3205-3214.
8. Sen, M., K. Lauterbach, H. El-Gabalawy, G. S. Firestein, M. Corr, and D. A. Carson. 2000. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 97:2791-2796.
9. Blumenthal, A., S. Ehlers, J. Lauber, J. Buer, C. Lange, T. Goldmann, H. Heine, E. Brandt, and N. Reiling. 2006. The Wingless homolog WNT5A and its receptor Frizzled-5 regulate inflammatory responses of human mononuclear cells induced by microbial stimulation. Blood 108:965-973.
10. Pereira, C., D. J. Schaer, E. B. Bachli, M. O. Kurrer, and G. Schoedon. 2008. Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler. Thromb. Vasc. Biol. 28:504-510.
11. Reischl, J., S. Schwenke, J. M. Beekman, U. Mrowietz, S. Stürzebecher, and J. F. Heubach. 2007. Increased expression of Wnt5a in psoriatic plaques. J. Invest. Dermatol. 127:163-169.
12. Christman, M. A., II, D. J. Goetz, E. Dickerson, K. D. McCall, C. J. Lewis, F. Benencia, M. J. Silver, L. D. Kohn, and R. Malgor. 2008. Wnt5a is expressed in murine and human atherosclerotic lesions. Am. J. Physiol. Heart Circ. Physiol. 294:H2864-H2870.
13. Ouchi, N., A. Higuchi, K. Ohashi, Y. Oshima, N. Gokce, R. Shibata, Y. Akasaki, A. Shimono, and K. Walsh. 2010. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 329:454-457.
14. Choy, D. F., B. Modrek, A. R. Abbas, S. Kummerfeld, H. F. Clark, L. C. Wu, G. Fedorowicz, Z. Modrusan, J. V. Fahy, P. G. Woodruff, and J. R. Arron. 2011. Gene expression patterns of Th2 inflammation and intercellular communication in asthmatic airways. J. Immunol. 186:1861-1869.
15. Kim, J., J. Kim, D. W. Kim, Y. Ha, M. H. Ihm, H. Kim, K. Song, and I. Lee. 2010. Wnt5a induces endothelial inflammation via beta-catenin-independent signaling. J. Immunol. 185:1274-1282.
16. Tickenbrock, L., J. Schwäble, A. Strey, B. Sargin, S. Hehn, M. Baas, C. Choudhary, V. Gerke, W. E. Berdel, C. Müller-Tidow, and H. Serve. 2006. Wnt signaling regulates transendothelial migration of monocytes. J. Leukoc. Biol. 79:1306-1313.
17. Manicassamy, S., B. Reizis, R. Ravindran, H. Nakaya, R. M. Salazar-Gonzalez, Y. C. Wang, and B. Pulendran. 2010. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329:849-853.
18. Martin, M., K. Rehani, R. S. Jope, and S. M. Michalek. 2005. Toll-like receptormediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6:777-784.
19. Zhang, P., J. Katz, and S. M. Michalek. 2009. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol. Immunol. 46:677-687.
20. Neumann, J., K. Schaale, K. Farhat, T. Endermann, A. J. Ulmer, S. Ehlers, and N. Reiling. 2010. Frizzled1 is a marker of inflammatory macrophages, and its ligand Wnt3a is involved in reprogramming Mycobacterium tuberculosisinfected macrophages. FASEB J. 24:4599-4612.
21. Potok, M. A., K. B. Cha, A. Hunt, M. L. Brinkmeier, M. Leitges, A. Kispert, and S. A. Camper. 2008. WNT signaling affects gene expression in the ventral diencephalon and pituitary gland growth. Dev. Dyn. 237:1006-1020.
22. Reiling, N., C. Hölscher, A. Fehrenbach, S. Kröger, C. J. Kirschning, S. Goyert, and S. Ehlers. 2002. Cutting edge: Toll-like receptor (TLR) 2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J. Immunol. 169:3480-3484.
23. Zhang, X., R. Goncalves, and D. M. Mosser. 2008. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. Chapter: Unit 14.1.
24. Grage-Griebenow, E., D. Lorenzen, R. Fetting, H. D. Flad, and M. Ernst. 1993. Phenotypical and functional characterization of Fc gamma receptor I (CD64) - negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity. Eur. J. Immunol. 23:3126-3135.
25. Reiling, N., A. Blumenthal, H. D. Flad, M. Ernst, and S. Ehlers. 2001. Mycobacteria-induced TNF-alpha and IL-10 formation by human macrophages is differentially regulated at the level of mitogen-activated protein kinase activity. J. Immunol. 167:3339-3345.
26. Reiling, N., S. Homolka, K. Walter, J. Brandenburg, L. Niwinski, M. Ernst, C. Herzmann, C. Lange, R. Diel, S. Ehlers, and S. Niemann. 2013. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. mBio 4: pii: e00250-13.
27. Song, H., R. Sandie, Y. Wang, M. A. Andrade-Navarro, and M. Niederweis. 2008. Identification of outer membrane proteins of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 88:526-544.
28. Itäranta, P., Y. Lin, J. Peräsaari, G. Roël, O. Destrée, and S. Vainio. 2002. Wnt-6 is expressed in the ureter bud and induces kidney tubule development in vitro. Genesis 32:259-268.
29. Listenberger, L. L., and D. A. Brown. 2007. Fluorescent detection of lipid droplets and associated proteins. Curr. Protoc. Cell Biol. Chapter 24: Unit 24.2.
30. Hölscher, C., N. Reiling, U. E. Schaible, A. Hölscher, C. Bathmann, D. Korbel, I. Lenz, T. Sonntag, S. Kröger, S. Akira, et al. 2008. Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. Eur. J. Immunol. 38:680-694.
31. Willems, E., L. Leyns, and J. Vandesompele. 2008. Standardization of real-time PCR gene expression data from independent biological replicates. Anal. Biochem. 379:127-129.
32. Leung, J. Y., F. T. Kolligs, R. Wu, Y. Zhai, R. Kuick, S. Hanash, K. R. Cho, and E. R. Fearon. 2002. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. 277:21657-21665.
33. He, T. C., A. B. Sparks, C. Rago, H. Hermeking, L. Zawel, L. T. Da Costa, P. J. Morin, B. Vogelstein, and K. W. Kinzler. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
34. Coghlan, M. P., A. A. Culbert, D. A. Cross, S. L. Corcoran, J. W. Yates, N. J. Pearce, O. L. Rausch, G. J. Murphy, P. S. Carter, L. Roxbee Cox, et al. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7:793-803.
35. Kühl, M., L. C. Sheldahl, M. Park, J. R. Miller, and R. T. Moon. 2000. The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16:279-283.
36. Malbon, C. C., H. Wang, and R. T. Moon. 2001. Wnt signaling and heterotrimeric G-proteins: strange bedfellows or a classic romance? Biochem. Biophys. Res. Commun. 287:589-593.
37. Bain, J., L. Plater, M. Elliott, N. Shpiro, C. J. Hastie, H. McLauchlan, I. Klevernic, J. S. C. Arthur, D. R. Alessi, and P. Cohen. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408:297-315.
38. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8:958-969.
39. Ghassabeh, G. H., P. De Baetselier, L. Brys, W. Noël, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108:575-583.
40. Youle, R. J., and A. Strasser. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9:47-59.
41. Roussel, M. F. 1997. Regulation of cell cycle entry and G1 progression by CSF-1. Mol. Reprod. Dev. 46:11-18.
42. Vistejnova, L., J. Dvorakova, M. Hasova, T. Muthny, V. Velebny, K. Soucek, and L. Kubala. 2009. The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. Neuroendocrinol. Lett. 30 (Suppl. 1):121-127.
43. Dugo, L., M. Collin, and C. Thiemermann. 2007. Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock 27:113-123.
44. Cáceres, N., G. Tapia, I. Ojanguren, F. Altare, O. Gil, S. Pinto, C. Vilaplana, and P.-J. Cardona. 2009. Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models. Tuberculosis (Edinb.) 89:175-182.
45. Peyron, P., J. Vaubourgeix, Y. Poquet, F. Levillain, C. Botanch, F. Bardou, M. Daffé, J.-F. Emile, B. Marchou, P.-J. Cardona, et al. 2008. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M.tuberculosis persistence. PLoS Pathog. 4:e1000204.
46. Keller, C., J. Lauber, A. Blumenthal, J. Buer, and S. Ehlers. 2004. Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages. Tuberculosis (Edinb.) 84:144-158.
47. Saban, R., M. R. D'Andrea, P. Andrade-Gordon, C. K. Derian, I. Dozmorov, M. A. Ihnat, R. E. Hurst, C. Simpson, and M. R. Saban. 2007. Regulatory network of inflammation downstream of proteinase-activated receptors. BMC Physiol. 7:3.
48. You, J., A. V. Nguyen, C. G. Albers, F. Lin, and R. F. Holcombe. 2008. Wnt pathway-related gene expression in inflammatory bowel disease. Dig. Dis. Sci. 53:1013-1019.
49. Von Toerne, C., C. Schmidt, J. Adams, E. Kiss, J. Bedke, S. Porubsky, N. Gretz, M. T. Lindenmeyer, C. D. Cohen, H.-J. Gröne, and P. J. Nelson. 2009. Wnt pathway regulation in chronic renal allograft damage. Am. J. Transplant. 9:2223-2239.
50. Liu, X., R. Lu, S. Wu, and J. Sun. 2010. Salmonella regulation of intestinal stem cells through the Wnt/beta-catenin pathway. FEBS Lett. 584:911-916.
51. Bartscherer, K., and M. Boutros. 2008. Regulation of Wnt protein secretion and its role in gradient formation. EMBO Rep. 9:977-982.
52. Shimizu, H., M. A. Julius, M. Giarré, Z. Zheng, A. M. Brown, and J. Kitajewski. 1997. Transformation by Wnt family proteins correlates with regulation of betacatenin. Cell Growth Differ. 8:1349-1358.
53. Gazit, A., A. Yaniv, A. Bafico, T. Pramila, M. Igarashi, J. Kitajewski, and S. A. Aaronson. 1999. Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene 18:5959-5966.
54. Varlakhanova, N. V., and P. S. Knoepfler. 2009. Acting locally and globally: Myc's ever-expanding roles on chromatin. Cancer Res. 69:7487-7490.
55. Larsen, E. C., J. A. Di Gennaro, N. Saito, S. Mehta, D. J. Loegering, J. E. Mazurkiewicz, and M. R. Lennartz. 2000. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J. Immunol. 165:2809-2817.
56. Benoit, M., B. Desnues, and J.-L. Mege. 2008. Macrophage polarization in bacterial infections. J. Immunol. 181:3733-3739.
57. El Kasmi, K. C., J. E. Qualls, J. T. Pesce, A. M. Smith, R. W. Thompson, M. Henao-Tamayo, R. J. Basaraba, T. König, U. Schleicher, M.-S. Koo, et al. 2008. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9:1399-1406.
58. Zeller, K. I., X. Zhao, C. W. H. Lee, K. P. Chiu, F. Yao, J. T. Yustein, H. S. Ooi, Y. L. Orlov, A. Shahab, H. C. Yong, et al. 2006. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. USA 103:17834-17839.
59. Pello, O. M., M. De Pizzol, M. Mirolo, L. Soucek, L. Zammataro, A. Amabile, A. Doni, M. Nebuloni, L. B. Swigart, G. I. Evan, et al. 2012. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 119:411-421.
60. Shin, K., J. Lee, N. Guo, J. Kim, A. Lim, L. Qu, I. U. Mysorekar, and P. A. Beachy. 2011. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472:110-114.
61. Jenkins, S. J., D. Ruckerl, P. C. Cook, L. H. Jones, F. D. Finkelman, N. Van Rooijen, A. S. MacDonald, and J. E. Allen. 2011. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332:1284-1288.
62. Ríos-Barrera, V. A., V. Campos-Peña, D. Aguilar-León, L. R. Lascurain, M. A. Meraz-Ríos, J. Moreno, V. Figueroa-Granados, and R. Hernández-Pando. 2006. Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence. Eur. J. Immunol. 36:345-353.
63. Hernandez-Pando, R., T. Schön, E. H. Orozco, J. Serafin, and I. Estrada-García. 2001. Expression of inducible nitric oxide synthase and nitrotyrosine during the evolution of experimental pulmonary tuberculosis. Exp. Toxicol. Pathol. 53:257-265.